Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Certain medical conditions or medications could make it unsafe
Maximizing results with tirzepatide niacinamide While tirzepatide is highly effective on its own, optimizing lifestyle factors can enhance outcomes and improve long-term sustainability
People can increase their physical activity at a gym or use home gym equipment, which may be more cost-effective
Even a modest weight loss of 5-10% of body weight can have a significant impact on improving metabolic health and reducing the risk of chronic diseases
Activation of this receptor is known to regulate normal feeding behavior and reward-driven feelings
